MET and neoplasm: Activation of the HGF/MET signaling pathway driven by a ligand (HGF)-dependent or ligand-independent manner promotes cellular proliferation, angiogenesis, tumor aggressiveness, and invasion, thereby resulting in poor survival outcomes (Mukai et al. 2020).